SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A), today announced the release of eArray 5.4 online microarray design tool, which enables users to design custom microRNA (miRNA) ...

Two companies will provide an end-to-end solution tailored to application services. Oxford Gene Technology (OGT) and Agilent Technologies completed a collaborative agreement giving OGT access to ...

PALO ALTO, Calif., Jan. 5, 2005 -- Agilent Technologies Inc. (NYSE: A) today announced a breakthrough development that enables the rapid advance of microarray-based comparative genomic studies in ...

A group of researchers has provided new insight into processes shaping the human genome. They used a clone-based method to build a comprehensive, fine-scale map of structural variation in eight human ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...

Agilent Technologies Inc. and Cogenics, a division of Clinical Data, Inc. have announced that Cogenics has been recertified, for the third year, as a Certified Microarray Service Provider for Agilent ...

The State of the Microarray | Selected Suppliers of Microarray Chips, Spotters, and Readers Courtesy of Amersham Biosciences Note: a = arrays; r = reader; s = spotter Affymetrix www.affymetrix.com - a ...

Microarrays, including genome tiling microarrays, are exceptionally powerful tools for querying diverse genomic features, including mapping gene expression and structure, analyzing polymorphisms, ...

Nearly a decade has passed since the first microarrays were created, and yet we are just beginning to see what can be achieved with this technology. Today's scientists are innovative and ...

Agilent Technologies Inc. (NYSE: A) today introduced a new series of targeting specific disease states. Two catalog products, the HaloPlex Cancer Research Panel and the HaloPlex Cardiomyopathy ...